Nr 546 nr546 week 8 - Study guides, Class notes & Summaries

Final Exam: NR546/ NR 546 (NEW Update 2024/ 2025) Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Review| Complete Guide with Questions and Verified Answers| 100% Correct- Chamberlain QUESTION MAOI use LAST choice for depression because of many potential, serious s/e QUESTION MAOI mech of action Answer: block enzymes responsible for the breakdown of 5HT, NE, DA - 2 primary forms of MAOI enzyme (MAOI-A and MAOI-B) -both are located in brain ...

Final Exam: NR546 / NR 546 (Latest Update 2024 / 2025) Advanced Pharmacology Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Guide | Weeks 5 - 8 Covered | Questions and Verified Answer s| 100% Correct - Chamberlain Q: Medication Management SSRI-Selective Serotonin Reuptake Inhibitors *Inhibit 5 HT reuptake SNRI-Serotonin Norepinephrine Reuptake Inhibitors *inhibit 5-HT reuptake *inhibit NE reuptake (increase energy, focus) *increase DA in prefrontal cortex (increase cogni...

Midterm Exam: NR546/ NR 546 (Latest Update 2024/ 2025) Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Guide |Weeks 1-4 Covered| Questions and Verified Answers| 100% Correct- Chamberlain Q: FGA side effects hyperprolactinemia, extrapyramidal symptom (EPS), QT pro- longation, tornadoes de pointes, blood dyscrasias, sedation, orthostatic hypoten- sion, dizziness. Q: Clozapine Answer: not indicated for use in acute presentation of schizophrenia, ab- solute n...

Final Exam: NR546/ NR 546 (Latest Update 2024/ 2025) Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Guide |Weeks 5-8 Covered| Questions and Verified Answers| 100% Correct- Chamberlain Q: Medication Management SSRI-Selective Serotonin Reuptake Inhibitors *Inhibit 5 HT reuptake SNRI-Serotonin Norepinephrine Reuptake Inhibitors *inhibit 5-HT reuptake *inhibit NE reuptake (increase energy, focus) *increase DA in prefrontal cortex (increase cognition) NDRI-Norepine...

NR 546 / NR546 Neurotransmitter Table * To be completed throughout course and submitted in Week 8* 2023/2024

Neuro transmitter Receptor Subtype Location/Function/Effects /symptoms of excess or deficit if applicable Distribution (ie: CNS/PNS, GI, vascular) Drug classes that target this neurotransmitter or receptor Specific medications that target this neurotransmitter or receptor Glutamate AMPA α-Amino-3-hydroxy-5- methyl-4- isoxazolepropionic acid (AMPA)-type glutamate receptors (AMPARs) mediate the majority of fast excitatory synaptic transmission in the brain. AMPA receptors ...

NR 546 Week 8 Neurotransmitter Table Chamberlain. Neuro transmitter Receptor Subtype Location/Function/Effects /symptoms of excess or deficit if applicable Distribution (ie: CNS/PNS, GI, vascular) Drug classes that target this neurotransmitter or receptor Specific medications that target this neurotransmitter or receptor Glutamate AMPA α-Amino-3-hydroxy-5- methyl-4- isoxazolepropionic acid (AMPA)-type glutamate receptors (AMPARs) mediate the majority of fast excitatory syn...

NR 546 Week 8 Course Reflection